Fig. 6From: Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapyExpression and modulation of guadecitabine-specific signature genes in baseline and on-treatment clinical samples from NIBIT-M4 patients. A. Heatmap of log2 fold changes of guadecitabine signature genes among the following comparisons: w4 vs. w0, w12 vs. w4 and w12 vs w0. B-D. Enrichment plots containing profiles of the running enrichment scores (ES) and positions of guadecitabine gene set members on the rank ordered list in GSEA for w4 vs. w0 (B), w12 vs. w4 (C) and w12 vs. w0 (D) comparisonsBack to article page